Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 4(5): e1000069, 2008 May 09.
Article in English | MEDLINE | ID: mdl-18464897

ABSTRACT

Inducible and reversible regulation of gene expression is a powerful approach for uncovering gene function. We have established a general method to efficiently produce reversible and inducible gene knockout and rescue in mice. In this system, which we named iKO, the target gene can be turned on and off at will by treating the mice with doxycycline. This method combines two genetically modified mouse lines: a) a KO line with a tetracycline-dependent transactivator replacing the endogenous target gene, and b) a line with a tetracycline-inducible cDNA of the target gene inserted into a tightly regulated (TIGRE) genomic locus, which provides for low basal expression and high inducibility. Such a locus occurs infrequently in the genome and we have developed a method to easily introduce genes into the TIGRE site of mouse embryonic stem (ES) cells by recombinase-mediated insertion. Both KO and TIGRE lines have been engineered for high-throughput, large-scale and cost-effective production of iKO mice. As a proof of concept, we have created iKO mice in the apolipoprotein E (ApoE) gene, which allows for sensitive and quantitative phenotypic analyses. The results demonstrated reversible switching of ApoE transcription, plasma cholesterol levels, and atherosclerosis progression and regression. The iKO system shows stringent regulation and is a versatile genetic system that can easily incorporate other techniques and adapt to a wide range of applications.


Subject(s)
Gene Expression , Gene Targeting , Transgenes , Animals , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Atherosclerosis/drug therapy , Atherosclerosis/pathology , Cholesterol/blood , Doxycycline/administration & dosage , Doxycycline/metabolism , Embryonic Stem Cells/physiology , Gene Expression/drug effects , Genetic Vectors/genetics , Insulator Elements , Mice , Mice, Transgenic , Mutagenesis, Insertional , Retroviridae/genetics , Trans-Activators/genetics , Trans-Activators/metabolism
2.
Development ; 131(20): 5185-95, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15459109

ABSTRACT

The nerve growth factor (NGF) receptor TrkA is widely expressed in non-neural tissues suggesting pleiotropic functions outside the nervous system. Based on pharmacological and immuno-depletion experiments, it has been hypothesized that NGF plays an important role in the normal development and function of the immune system. However, attempts to unravel these functions by conventional gene targeting in mice have been hampered by the early postnatal lethality caused by null mutations. We have developed a novel 'reverse conditional' gene targeting strategy by which TrkA function is restored specifically in the nervous system. Mice lacking TrkA in non-neuronal tissues are viable and appear grossly normal. All major immune system cell populations are present in normal numbers and distributions. However, mutant mice have elevated serum levels of certain immunoglobulin classes and accumulate B1 cells with aging. These data, confirmed in a classical reconstitution model using embryonic fetal liver from TrkA-null mice, demonstrate that endogenous NGF modulates B cell development through TrkA in vivo. Furthermore, they demonstrate that many of the dramatic effects previously reported by pharmacological or immuno-depletion approaches do not reflect physiological developmental roles of TrkA in the immune system.


Subject(s)
B-Lymphocytes/metabolism , Nerve Growth Factor/metabolism , Receptor, trkA/metabolism , Animals , B-Lymphocytes/immunology , Immune System/embryology , Immunoglobulins/blood , Immunologic Memory/genetics , Immunologic Memory/immunology , Mast Cells/immunology , Mast Cells/metabolism , Mice , Mice, Knockout , Nerve Growth Factor/deficiency , Nerve Growth Factor/genetics , Receptor, trkA/deficiency , Receptor, trkA/genetics , Receptor, trkA/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...